AMPLITUDE-O: Efpeglenatide reduces CV events, CKD progression in high-risk type 2 diabetes

Press/Media

Period	29 Jun 2021

Media coverage

Title	AMPLITUDE-O: Efpeglenatide reduces CV events, CKD progression in high-risk type 2 diabetes
Media name/outlet	Healio
Country/Territory	United States
Date	29/06/21
URL	https://www.healio.com/news/endocrinology/20210629/amplitudeo-efpeglenatide-reduces-cv-events-ckd-progression-in-highrisk-type-2-diabetes
Persons	David Lam, David Lam